About AOU Università degli Studi della Campania "Luigi Vanvitelli"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Agios Pharmaceuticals, Inc.
5
Janssen Research & Development, LLC
5
National Cancer Institute, Naples
5
Boehringer Ingelheim
3
Celgene
3
University of Campania "Luigi Vanvitelli"
3
Bayer
2
Bristol-Myers Squibb
2
EMD Serono Research & Development Institute, Inc.
2
Janssen-Cilag S.p.A.
2
Merck KGaA, Darmstadt, Germany
2
Clinical Trials at AOU Università degli Studi della Campania "Luigi Vanvitelli"
During the past decade, AOU Università degli Studi della Campania "Luigi Vanvitelli" conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 10 clinical trials were completed, i.e. on
average, 18.5% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 9 clinical trials were completed. i.e. 42.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
2011-11-01
2024-12-01
Active, not recruiting
525
Study to Evaluate the Effects of ACE-536 in Patients With Beta-thalassemia
2013-02-01
2015-11-01
Completed
64
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
2013-07-12
2019-06-04
Completed
402
Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
2013-11-01
2023-12-01
Active, not recruiting
406
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
2015-11-12
2018-11-28
Completed
580
Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer
2016-04-01
2024-07-01
Active, not recruiting
200
Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months
2016-04-18
2020-03-17
Completed
158
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
2016-10-05
2022-05-13
Completed
1,036
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "AOU Università degli Studi della Campania "Luigi Vanvitelli"" #1 sponsor was "Agios Pharmaceuticals, Inc." with 5 trials, followed by "Janssen Research & Development, LLC" with 5 trials
sponsored, "National Cancer Institute, Naples" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Celgene"
with 3 trials sponsored. Other sponsors include 32 different institutions and
companies that sponsored additional 32 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AOU Università degli Studi della Campania "Luigi Vanvitelli""
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator and "Bruschettini S.r.l." with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at AOU Università degli Studi della Campania "Luigi Vanvitelli"
According to Clinical.Site data, the most researched conditions in "AOU Università degli Studi della Campania "Luigi Vanvitelli"" are
"Pyruvate Kinase Deficiency" (3 trials), "Schizophrenia" (3 trials), "Anemia, Hemolytic" (2 trials), "Arthritis, Psoriatic" (2 trials) and "Chronic Kidney Disease" (2 trials). Many other conditions were trialed in "AOU Università degli Studi della Campania "Luigi Vanvitelli"" in a lesser frequency.
Clinical Trials Intervention Types at AOU Università degli Studi della Campania "Luigi Vanvitelli"
Most popular intervention types in "AOU Università degli Studi della Campania "Luigi Vanvitelli"" are "Drug" (55 trials), "Other" (5 trials), "Biological" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Cetuximab" (4 trials), "Bevacizumab" (3 trials), "Carboplatin" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at AOU Università degli Studi della Campania "Luigi Vanvitelli"
The vast majority of trials in "AOU Università degli Studi della Campania "Luigi Vanvitelli"" are
54 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at AOU Università degli Studi della Campania "Luigi Vanvitelli"
Currently, there are NaN active trials in "AOU Università degli Studi della Campania "Luigi Vanvitelli"".
undefined are not yet recruiting,
24 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in AOU Università degli Studi della Campania "Luigi Vanvitelli",
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in AOU Università degli Studi della Campania "Luigi Vanvitelli", 0 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 32 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of AOU Università degli Studi della Campania "Luigi Vanvitelli"
AOU Università degli Studi della Campania "Luigi Vanvitelli" has several departments that took part in Clinical trials: "AOU Seconda Università degli Studi; Dip.Assistenziale Integrato Medicina Int-I Clinica Neurologica" - 4 trials
Departments List